606099-85-8 Usage
Uses
Used in Pharmaceutical Synthesis:
2-AMINO-4-(4-NITROPHENYL)-3-FURONITRILE is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Research Applications:
In the research field, 2-AMINO-4-(4-NITROPHENYL)-3-FURONITRILE is utilized for studying its potential biological activity and exploring its properties for use in medicine.
Used in Anti-Cancer Applications:
2-AMINO-4-(4-NITROPHENYL)-3-FURONITRILE is being investigated for its potential use as an anti-cancer agent. Its specific chemical structure may contribute to the development of new cancer treatments.
Used in Antibacterial Applications:
2-AMINO-4-(4-NITROPHENYL)-3-FURONITRILE has also been studied for its potential as an antibacterial agent, which could lead to the creation of new antibiotics to combat bacterial infections.
Used in Antifungal Applications:
Furthermore, 2-AMINO-4-(4-NITROPHENYL)-3-FURONITRILE is being explored for its potential as an antifungal agent, indicating its broad-spectrum activity against various pathogens.
Check Digit Verification of cas no
The CAS Registry Mumber 606099-85-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,6,0,9 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 606099-85:
(8*6)+(7*0)+(6*6)+(5*0)+(4*9)+(3*9)+(2*8)+(1*5)=168
168 % 10 = 8
So 606099-85-8 is a valid CAS Registry Number.
606099-85-8Relevant articles and documents
Discovery of small molecule RIP1 kinase inhibitors for the treatment of pathologies associated with necroptosis
Harris, Philip A.,Bandyopadhyay, Deepak,Berger, Scott B.,Campobasso, Nino,Capriotti, Carol A.,Cox, Julie A.,Dare, Lauren,Finger, Joshua N.,Hoffman, Sandra J.,Kahler, Kirsten M.,Lehr, Ruth,Lich, John D.,Nagilla, Rakesh,Nolte, Robert T.,Ouellette, Michael T.,Pao, Christina S.,Schaeffer, Michelle C.,Smallwood, Angela,Sun, Helen H.,Swift, Barbara A.,Totoritis, Rachel D.,Ward, Paris,Marquis, Robert W.,Bertin, John,Gough, Peter J.
supporting information, p. 1238 - 1243 (2014/01/06)
Potent inhibitors of RIP1 kinase from three distinct series, 1-aminoisoquinolines, pyrrolo[2,3-b]pyridines, and furo[2,3-d]pyrimidines, all of the type II class recognizing a DLG-out inactive conformation, were identified from screening of our in-house ki
Kinase inhibitors
-
, (2008/06/13)
The present application is directed to pyrazolopyrimidine and furopyrimnidine analogs of the formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
Kinase inhibitors
-
Page 32, (2010/02/03)
The present application is directed to pyrazolopyrirnidine and furopyrimidine analogs of the formula (I) wherein the substituents are as defined herein, which are useful as kinase inhibitors.
